Unternehmen
Stellantis Unveils FaSTLAne 2030 Recovery Plan Targeting 8-10% Operating Margin
CEO Antonio Filosa outlined a 60 billion-euro investment roadmap, $2.4 billion in 2027 cost savings, and commitments to positive free cash flow from 2027 onward.
Coinbase charts path beyond crypto at Citi TMT conference
Coinbase CFO Alesia Haas outlined plans to expand the platform into prediction markets, tokenized equities, and agentic payments, as the company pushes toward an "everything exchange."
Nuvation Bio highlights pipeline progress and cash strength at Cantor conference
CEO David and CFO Philip outlined IBTROZI's market potential, safusidenib data and a $700 million cash reserve, while the stock traded around $6.30.
Crescent Biopharma Outlines Global Trial Roadmap at Cantor Conference
The biotech said CR-001, a VEGF-PD-1 bispecific, targets 50%-70% response rates matching ivonescimab, with Phase I data due in early 2027 and global registration trials expected soon after.
ORIC Pharmaceuticals Highlights Pipeline Progress at Cantor Fitzgerald Healthcare Conference
Biotech CEO Jacob Chacko outlined Enosartib and rinzimetostat trial timelines while noting Pfizer's MEVPRO readout window and $388M cash runway through mid-2028.
Aon to Acquire USI for $6.5B Revenue Platform
Aon plans to acquire USI Insurance Services, creating a $6.5 billion revenue platform, with synergies expected to generate $395 million in EBITDA. The deal is valued at 14.5 times projected synergies.
Brenntag issues €500 million bond at 4.25% coupon
German chemical distributor Brenntag SE placed a €500 million seven‑year bond priced at 99.626% of face value, offering a 4.25% coupon for general corporate purposes.
Uber Reports 20%+ Growth, Unveils AV and Membership Strategy
Uber CEO Dara Khosrowshahi highlighted top-line growth exceeding 20% for four consecutive quarters, a 50-million-member Uber One base, and a clear path to $50,000–$60,000 autonomous-vehicle costs at the Goldman Sachs Communacopia conference.
BioMarin Sees VOXZOGO on Track for $1B in 2026 Sales at Citi Summit
BioMarin's CEO highlighted strong VOXZOGO momentum and a broadening pipeline at the Citi Biopharma Back to School Summit, projecting $1.0B–$1.05B in full-year revenue.
Arista projects 40% revenue rise, AI mix to drive 2028 scale‑up revenue
Arista Networks forecasts $12.6 bn revenue for 2025, 62‑64% gross margins and zero scale‑up Ethernet revenue in 2026, with AI‑driven sales expected to start in 2028.
CNO Financial Raises ROE Target, Backs $170M Tech Overhaul at KBW Conference
Insurance maker raises return-on-equity target to mid-teens and announced a $170 million three-year technology investment as broker-dealer assets hit $19 billion.
Pharvaris oral HAE drug shows 87% attack reduction in Phase III data
Deucrictibant cut hereditary angioedema attacks by 87% in Phase III CHAPTER-3, as Pharvaris prepares on-demand launch and prophylaxis filing.
Intuit’s 2026 Growth Strategy: AI-Driven Expansion and Revenue Reset
Intuit outlined a J-curve growth strategy at Goldman Sachs’ 2026 conference, prioritizing long-term platform expansion over near-term revenue gains, with AI integration accelerating product adoption and monetization.
Knightscope Outlines Security Agent Model in New Field Brief
The company details its five-tiered agent roles and compensation structure in a third installment of its series, targeting GSX 2026 attendees.
Swiss Savers Prioritize Security Over Wealth Building, Migros Bank Survey Finds
A new Migros Bank study reveals nearly 60% of Swiss regularly save, with 43% prioritizing capital preservation over the 31% focused on long-term wealth accumulation.
Danaos Stock Hits 52-Week High as Q2 Earnings Beat
Danaos Corp shares reached $155.89, their highest level in a year, after second-quarter results beat estimates on stronger dry bulk rates and lower interest costs.
Workday Names Sarah Kennedy Ellis Chief Marketing Officer
Google and Adobe veteran joins Workday as CMO on Oct. 5, leading global marketing and communications for the enterprise software maker.
UBS Pays €5 Million to Settle Dutch Tax Case Tied to Former Credit Suisse
Swiss bank reaches agreement with Dutch prosecutors over alleged incorrect tax filings for 12 former Credit Suisse clients spanning 2005–2015.
Swiss Re posts $2.8B in H1 profit, on track for full-year target — AM Best
Reinsurer's first-half net profit of $2.8 billion already exceeds 60% of its $4.5 billion annual goal, earning a stable outlook from AM Best.
PCI-PAL names BT reseller partner for business payment solutions
PCI-PAL has confirmed British Telecommunications plc as its telecommunications reseller for secure payment solutions for business communications, completing onboarding since the March agreement.
ESG Ratings Lose Luster as Climate Adaptation Takes Center Stage for Investors
Bain & Company says green ratings alone no longer signal attractive investments; pension funds with long horizons stand to gain by targeting climate-adaptation opportunities.
BrightSpring sees growth broaden across pharmacy and provider businesses
BrightSpring Health Services reported accelerating pharmacy EBITDA growth nearing 40%, provider unit expansion of about 20%, and a moderated inflation Reduction Act impact as it discussed strategy at the Wells Fargo healthcare conference.
Travere Therapeutics reports $489M cash and $3B sales potential for FILSPARI at Cantor conference
At the 12th Annual Cantor Fitzgerald Global Healthcare Conference, Travere outlined a mid‑20% gross‑to‑net range for FILSPARI, a cash balance of $489 million and a peak‑sales outlook above $3 billion.
NovaBridge Biosciences outlines pipeline progress at Cantor healthcare conference
The clinical-stage biotech described Phase III plans for its gastric cancer lead givastomig and ophthalmology asset VIS-101 as shares sit near six-month lows.
Rocket Pharmaceuticals details cardiomyopathy pipeline at Cantor Healthcare Conference
CEO Gaurav Shah highlighted AAV dosing strategies for Danon disease and discussed KRESLADI's commercial launch timeline during a conference presentation focused on rare genetic heart conditions.